These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18525322)

  • 1. The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography-inductively coupled plasma mass spectrometry.
    Brouwers EE; Huitema AD; Schellens JH; Beijnen JH
    Anticancer Drugs; 2008 Jul; 19(6):621-30. PubMed ID: 18525322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of sodium thiosulfate on the metabolism of cis-platin in human plasma in vitro.
    Sooriyaarachchi M; Narendran A; Gailer J
    Metallomics; 2012 Aug; 4(9):960-7. PubMed ID: 22842879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-milliliter wet-digestion for inductively coupled plasma mass spectrometry (ICP-MS): determination of platinum-DNA adducts in cells treated with platinum(II) complexes.
    Yamada K; Kato N; Takagi A; Koi M; Hemmi H
    Anal Bioanal Chem; 2005 Aug; 382(7):1702-7. PubMed ID: 15959768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity.
    Uozumi J; Ishizawa M; Iwamoto Y; Baba T
    Cancer Chemother Pharmacol; 1984; 13(2):82-5. PubMed ID: 6540631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early biotransformations of oxaliplatin after its intravenous administration to cancer patients.
    Allain P; Heudi O; Cailleux A; Le Bouil A; Larra F; Boisdron-Celle M; Gamelin E
    Drug Metab Dispos; 2000 Nov; 28(11):1379-84. PubMed ID: 11038167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical instability and methods for measurement of cisplatin adducts formed by interactions with cysteine and glutathione.
    Heudi O; Brisset H; Cailleux A; Allain P
    Int J Clin Pharmacol Ther; 2001 Aug; 39(8):344-9. PubMed ID: 11515709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-acetyl-L-cysteine modulates the metabolism of cis-platin in human plasma in vitro.
    Sooriyaarachchi M; Narendran A; Gailer J
    Metallomics; 2013 Mar; 5(3):197-207. PubMed ID: 23443244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gemcitabine on cis-platinum-DNA adduct formation and repair in a panel of gemcitabine and cisplatin-sensitive or -resistant human ovarian cancer cell lines.
    Peters GJ; Van Moorsel CJ; Lakerveld B; Smid K; Noordhuis P; Comijn EC; Weaver D; Willey JC; Voorn D; Van der Vijgh WJ; Pinedo HM
    Int J Oncol; 2006 Jan; 28(1):237-44. PubMed ID: 16328001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inductively coupled plasma mass spectrometric analysis of the total amount of platinum in DNA extracts from peripheral blood mononuclear cells and tissue from patients treated with cisplatin.
    Brouwers EE; Tibben MM; Pluim D; Rosing H; Boot H; Cats A; Schellens JH; Beijnen JH
    Anal Bioanal Chem; 2008 May; 391(2):577-85. PubMed ID: 18385987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
    van Moorsel CJ; Pinedo HM; Veerman G; Bergman AM; Kuiper CM; Vermorken JB; van der Vijgh WJ; Peters GJ
    Br J Cancer; 1999 Jun; 80(7):981-90. PubMed ID: 10362105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic schedule finding study of the combination of gemcitabine and cisplatin in patients with solid tumors.
    van Moorsel CJ; Kroep JR; Pinedo HM; Veerman G; Voorn DA; Postmus PE; Vermorken JB; van Groeningen CJ; van der Vijgh WJ; Peters GJ
    Ann Oncol; 1999 Apr; 10(4):441-8. PubMed ID: 10370787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of cisplatin and hemoglobin interactions using nanospray mass spectrometry and liquid chromatography with inductively-coupled plasma mass spectrometry.
    Mandal R; Teixeira C; Li XF
    Analyst; 2003 Jun; 128(6):629-34. PubMed ID: 12866879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for speciation of Pt in human serum incubated with cisplatin, oxaliplatin and carboplatin by conjoint liquid chromatography on monolithic disks with UV and ICP-MS detection.
    Martinčič A; Cemazar M; Sersa G; Kovač V; Milačič R; Ščančar J
    Talanta; 2013 Nov; 116():141-8. PubMed ID: 24148385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.
    Mandal R; Kalke R; Li XF
    Chem Res Toxicol; 2004 Oct; 17(10):1391-7. PubMed ID: 15487901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining TBP-based rOFFGEL-IEF with FASP and nLC-ESI-LTQ-MS/MS for the analysis of cisplatin-binding proteins in rat kidney.
    Moraleja I; Moreno-Gordaliza E; Mena ML; Gómez-Gómez MM
    Talanta; 2014 Mar; 120():433-42. PubMed ID: 24468393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative protein binding, stability and degradation of satraplatin, JM118 and cisplatin in human plasma in vitro.
    Bell DN; Liu JJ; Tingle MD; Rattel B; Meyer TU; McKeage MJ
    Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1440-6. PubMed ID: 18671714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sodium thiosulfate on ototoxicity and pharmacokinetics after cisplatin treatment in guinea pigs.
    Saito T; Zhang ZJ; Manabe Y; Ohtsubo T; Saito H
    Eur Arch Otorhinolaryngol; 1997; 254(6):281-6. PubMed ID: 9248736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gel electrophoresis in combination with laser ablation-inductively coupled plasma mass spectrometry to quantify the interaction of cisplatin with human serum albumin.
    Sullivan MP; Morrow SJ; Goldstone DC; Hartinger CG
    Electrophoresis; 2019 Sep; 40(18-19):2329-2335. PubMed ID: 31087392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.